Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 168	$ 183
Receivables, net	600	681
Inventories, net	741	755
Prepaid expenses and other current assets	113	106
Total current assets	1,622	1,725
Property, plant and equipment, net of accumulated depreciation and amortization of $2,621 and $2,530, respectively	1,322	1,334
Operating lease right-of-use assets	349	342
Goodwill	1,553	1,558
Trademarks, net	685	687
Other intangible assets, net	183	197
Other assets	331	315
Total assets	6,045	6,158
Current liabilities
Notes and loans payable	209	237
Current operating lease liabilities	80	78
Accounts payable and accrued liabilities	1,589	1,469
Total current liabilities	1,878	1,784
Long-term debt	2,476	2,474
Long-term operating lease liabilities	318	314
Other liabilities	826	791
Deferred income taxes	56	66
Total liabilities	5,554	5,429
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2022 and June 30, 2022; and 123,478,269 and 123,152,132 shares outstanding as of December 31, 2022 and June 30, 2022, respectively	131	131
Additional paid-in capital	1,207	1,202
Retained earnings	782	1,048
Treasury stock, at cost: 7,263,192 and 7,589,329 shares as of December 31, 2022 and June 30, 2022, respectively	(1,297)	(1,346)
Accumulated other comprehensive net (loss) income	(502)	(479)
Total Clorox stockholders’ equity	321	556
Noncontrolling interests	170	173
Total stockholders’ equity	491	729
Total liabilities and stockholders’ equity	$ 6,045	$ 6,158